Latest Prostate cancer Stories
--Brand Expands New Apparel and Accessories to Successful Pediatric, Breast, and Prostate Cancer Awareness Collections, Aiding in the Fight Against Cancer-- IRVINE,
The Majority of Surveyed Non-Prescribers Anticipate Prescribing Xofigo Within the Next Six Months, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug.
Study Correlates Immune Response with Improved Survival in Prostate Cancer Patients after Receiving the Antigen Express Novel Immunotherapeutic AE37 WORCESTER, Mass.
Study Achieved Primary Endpoint of Predicting Recurrence after Surgery and Reconfirmed Original Adverse Pathology Endpoint from Published UCSF Validation Study REDWOOD CITY, Calif.,
Active Surveillance Provides Low-Risk Patients Less Harmful Treatment Option NORTHFIELD, Ill., Aug.
9th Annual Race Supports Lung Cancer Research SOUTHAMPTON, N.Y., Aug.
POINT ROBERTS, Wash. and NEW YORK, Aug.
Demands Manufacturers Prove Claims of Safety and Benefits For Prostate Cancer Treatments CORAL SPRINGS, Fla., Aug.
According to relationship specialist Dr.
OXFORD, England, July 29, 2014 /PRNewswire/ -- Glide Pharmaceutical Technologies Ltd (Glide Pharma) today announced that it has taken an exclusive worldwide licence to
More Images (2 images) »